This Mentored Research Scientist Development Award application will provide an intensive research, training, and career development program for Dr. Michelle Odden, an epidemiologist and developing investigator at the University of California, San Francisco (UCSF). Her long-term career goal is to become a leader in the evidence-based prevention of cardiovascular disease (CVD) and related comorbid conditions in elderly adults. Older adults are living longer and healthier lives, yet much of the current literature on CVD epidemiology and prevention has been derived from younger populations. In this application, Dr. Odden will develop a comprehensive evidence base for prevention of CVD events in adults aged 75 years and older. Guided by her mentorship team, Dr. Odden will identify the strongest risk factors for CVD in the Cardiovascular Health Study, an ongoing NIH-funded cohort study of elderly adults. She will use the results of these analyses to inform computer simulations of CVD in older adults, in order to identify the most promising interventions for CVD prevention at the lowest risk for unintended side effects. Dr. Odden will conduct these simulations with the CHD Policy Model, an established computer model of CVD in the U.S. population. To achieve these goals, Dr. Odden and her mentors have developed the following specific aims:1) To describe the epidemiology of CVD events in adults 75 years and older, and to identify the strongest determinants of CVD events, among both traditional and age-related risk factors;2) To forecast CVD incidence, prevalence, mortality, and quality of life in U.S. adults aged 75 years and older, by incorporating in-depth, novel epidemiological data into an established CVD computer model;3) To estimate the potential impact of prevention strategies for CVD in U.S. adults aged 75 years and older on the extension of healthy life years, based on an established CVD computer model. The long term goal of this research is to prevent CVD events in adults over 75, and to extend the healthy years of life for older adults. This research supports the National Institutes of Health's mission to prevent disease and improve the health and well-being of Americans. The primary training goals of this application are to build a foundation of knowledge and skill set that will prepare Dr. Odden to be a successful independent researcher in translational research - from research to practice - in older adults. Through the training and the mentorship of a multidisciplinary team comprised of senior investigators at UCSF, and accomplished external advisors, she will learn the principles of gerontologic clinical science and cardiovascular prevention, and expand her methodological expertise to include forecasting and decision analysis methods. Additional training in implementation and dissemination science will enable her to translate her research findings into public health and clinical practice recommendations. She will participate in the Clinical and Translational K Scholars Program, offered by the UCSF Clinical and Translational Science Institute, which will offer crucial support and mentoring as she develops her research program in translational aging research.
The proposed research will improve our understanding of the determinants of cardiovascular disease in adults over age 75 years, and identify the optimal strategies for prevention, at the lowest risk of unintended side effects. This research will improve public health by reducing the burden of cardiovascular disease in older adults and extending the healthy years of life.
|Odden, Michelle C; Moran, Andrew E; Coxson, Pamela G et al. (2016) Gait Speed as a Guide for Blood Pressure Targets in Older Adults: A Modeling Study. J Am Geriatr Soc 64:1015-23|
|MejÃa, Shannon T; Settersten Jr, Richard A; Odden, Michelle C et al. (2016) Responses to Financial Loss During the Great Recession: An Examination of Sense of Control in Late Midlife. J Gerontol B Psychol Sci Soc Sci 71:734-44|
|Charlesworth, Christina J; Peralta, Carmen A; Odden, Michelle C (2016) Functional Status and Antihypertensive Therapy in Older Adults: A New Perspective on Old Data. Am J Hypertens 29:690-5|
|Wu, Chenkai; Shlipak, Michael G; Stawski, Robert S et al. (2016) Visit-to-Visit Blood Pressure Variability and Mortality and Cardiovascular Outcomes Among Older Adults: The Health, Aging, and Body Composition Study. Am J Hypertens :|
|Wallace, Erin R; Siscovick, David S; Sitlani, Colleen M et al. (2016) Incident Atrial Fibrillation and Disability-Free Survival in the Cardiovascular Health Study. J Am Geriatr Soc 64:838-43|
|Odden, Michelle C; McClure, Leslie A; Sawaya, B Peter et al. (2016) Achieved Blood Pressure and Outcomes in the Secondary Prevention of Small Subcortical Strokes Trial. Hypertension 67:63-9|
|Odden, Michelle C; Wu, Chenkai; Shlipak, Michael G et al. (2016) Blood Pressure Trajectory, Gait Speed, and Outcomes: The Health, Aging, and Body Composition Study. J Gerontol A Biol Sci Med Sci 71:1688-1694|
|Odden, Michelle C; Beilby, Pamela R; Peralta, Carmen A (2015) Blood Pressure in Older Adults: the Importance of Frailty. Curr Hypertens Rep 17:55|
|Moran, Andrew E; Odden, Michelle C; Thanataveerat, Anusorn et al. (2015) Cost-effectiveness of hypertension therapy according to 2014 guidelines. N Engl J Med 372:447-55|
|Odden, Michelle C (2015) A Discontinuation Trial of Antihypertensive Treatment: The Other Side of the Story. JAMA Intern Med 175:1630-2|
Showing the most recent 10 out of 29 publications